Bilaketaren emaitzak - S. Pellerito

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumato... nork M. Maset, E. Mansutti, M. Fabris, S. Lombardi, M. Saracco, S. Salvin, L. Quartuccio, S. Pellerito, S. De Vita

Connect to this object online.

Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RU... nork L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

Connect to this object online.

Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis nork F. Fischetti, L.M. Bambara, A. Carletto, M. Cutolo, P. Sarzi-Puttini, R. Pellerito, C. Fabro, E. Pontarini, M.A. Cimmino, P. Morassi, F. Atzeni, M. Saracco, M. Manfredi, M. Benucci, S. Lombardi, L. Quartuccio, M. Fabris, F. Curcio, E. Tonutti, S. De VIta

Connect to this object online.